• 제목/요약/키워드: embryonal carcinoma

검색결과 27건 처리시간 0.023초

종격동에 발생한 태생암 1례 (Embryonal Carcinoma of the Mediastinum)

  • 곽상룡;홍기우;김주현
    • Journal of Chest Surgery
    • /
    • 제11권3호
    • /
    • pp.364-367
    • /
    • 1978
  • Embryonal carcinoma of the mediastinum is a very uncommon disease. This is a report of an embryonal carcinoma in the mediastinum found in a 25 years old Korean male patient who had been suffering from chest pain and intractable coughing for 6 months. 5 weeks prior to this admission hemoptysis and high fever were followed. Right exploratory thoracotomy was performed under the impression of a mediastinal tumor, but found to be unresectable. Irradiation therapy was tried, but no response was observed. Patient expired on 78th day postoperatively.

  • PDF

우심실 종괴로 나타난 고환 태생암의 심장 전이 (Intracardiac Metastasis of Testicular Embryonal Carcinoma That Presented with a Right Ventricular Mass)

  • 심만식;김욱성;성기익;이영탁;박표원;임호영
    • Journal of Chest Surgery
    • /
    • 제43권1호
    • /
    • pp.81-85
    • /
    • 2010
  • 심장 전이는 환자가 사망하기 전에 진단되는 경우가 드물다. 저자들은 고환 융모암의 다발성전이를 보였던 26세 남자에서 심장 전이를 진단하였고 심장초음파에서 심실중격에서 기원하여 우심실유출로에 유동하는 종괴를 확인할 수 있었다. 우심실로부터 제거한 종괴의 조직학적 소견은 고환 융모암에 합당한 소견을 보였고 환자는 수술적 치료 및 항암화학요법 후에 안정된 회복을 보였다. 국내에는 고환 융모암의 심장 전이를 수술적으로 제거함으로써 성공적인 치료 효과를 보였던 증례 보고가 없어 보고하고자 한다.

P19 배아 암종 줄기세포에서 RNA 간섭에 의한 Nanog 유전자 발현의 특이적 억제 (Specific Knockdown of Nanog Expression by RNA Interference in P19 Embryonal Carcinoma Stem Cells)

  • 최승철;임도선
    • 한국발생생물학회지:발생과생식
    • /
    • 제12권2호
    • /
    • pp.159-168
    • /
    • 2008
  • Nanog is a newly identified member of the homeobox family of DNA binding transcription factors that functions to maintain the undifferentiated state of stem cells. However, molecular mechanisms underlying the function of Nanog remain largely unknown. To elucidate the regulatory roles of Nanog involved in maintenance of P19 embryonal carcinoma (EC) stem cells, we transfected three small interfering RNA (siRNA) duplexes targeted against different regions of the Nanog gene into P19 cells. The Nanog siRNA-100 duplexes effectively decreased the expression of Nanog up to 30.7% compared to other two Nanog siRNAs, the Nanog siRNA-400 (67.9 %) and -793 (53.0%). When examined by RT-PCR and real-time PCR, the expression of markers for pluripotency such as Fgf4, Oct3/4, Rex1, Sox1 and Yes was downregulated at 48 h after transfection with Nanog siRNA-100. Furthermore, expression of the ectodermal markers, Fgf5 and Isl1 was reduced by Nanog knockdown. By contrast, the expression of other markers for pluripotency such as Cripto, Sox2 and Zfp57 was not affected by Nanog knockdown at this time. On the other hand, the expression of Lif/Stat3 pathway molecules and of the endoderm markers including Dab2, Gata4, Gata6 and the germ cell nuclear factor was not changed by Nanog knockdown. The results of this study demonstrated that the knockdown of Nanog expression by RNA interference in P19 cells was sufficient to modulate the expression of pluripotent markers involved in the self-renewal of EC stem cells. These results provide the valuable information on potential downstream targets of Nanog and add to our understanding of the function of Nanog in P19 EC stem cells.

  • PDF

후종격동에 발생한 원발성 종격동 태생암 1예 (A Case of Primary Mediastinal Embryonal Carcinoma Arising in the Posterior Mediastinum)

  • 임근우;강홍모;김태중;임을순;강경의;조용선;한민수;유지홍
    • Tuberculosis and Respiratory Diseases
    • /
    • 제47권1호
    • /
    • pp.117-122
    • /
    • 1999
  • 저자 등은 아무런 증상이 없던 37세 남자에서 후종격동에서 발생하였고 진단당시 증상이 없었으며 암표식자의 증가를 동반하지 않았던 비전형적인 원발성 종격동 태생암 l례를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

배종양 세포와 체세포 간의 융합 세포에서 X 염색체 재활성화의 조절과 성염색체에 대한 상염색체 비율의 결정 (Control of X Chromosome Reactivation and Determination of the Ratio of Sex Chromosome to Autosome in Embryonal Carcinoma Cell-Somatic Cell Hybrids)

  • 이광호
    • 한국동물학회지
    • /
    • 제39권1호
    • /
    • pp.75-88
    • /
    • 1996
  • OTF9-63 (OTF9)와 P19S1O1A1 (P19) 배종양 세포들의 체세포에 존재하는 불화성 X 염색체의 재활성과 유발 능력을 조사하였다. 배종야 세포와 체세포들의 융합에 의해 얻어진 HATr 클론들의 형태, 염색체 복제 양상을 비롯하여 X 염색체에 존재하나 그 위치는 상당히 먼 유전자들인 Hprt와 Pgk-1의 발현 양상을 분석한 결과, OTF9 세포는 불활성 X 염색체를 재활성화 시킬 수 있는데 반해 P19 세포는 불가능한 것으로 나타났다. 또한, 모든 유합세포는 장기간 배양되었을 때 성염색체의 수가 감소하였으며, 결국 1:2의 성염색체:상염색체의 비율을 나타내었다. 배종양 세포-체세포 융합세포의 이용은 초기 배발생 과정에서 시작되어 난자형성 과정의 감수분열 전까지의 유지되는 X 념색체의 재활성화 기작을 연구하기 위한 실험 방법을 제공한다.

  • PDF

새열낭종 기원의 편평세포암종 1예 (A Case of Branchiogenic Squamous Cell Carcinoma)

  • 박병건
    • 대한두경부종양학회지
    • /
    • 제27권2호
    • /
    • pp.240-242
    • /
    • 2011
  • Branchiogenic carcinoma is extremely rare and is defined as a malignant degeneration within the confines of epithelial remnants derived from the embryonal branchial apparatus. Two major diagnostic criteria are histologic proof of transitional area from normal cyst epithelium to invasive squamous cell carcinoma and absence of an identifiable primary carcinoma elsewhere. A 62-year old woman visited our department complaining of a non-tender, movable mass in left upper lateral neck. After a complete mass excision, histopathologic diagnosis of the surgical specimen was branchiogenic squamous cell carcinoma. I report a case of branchiogenic carcinoma with literature review.

Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients

  • Fan, Gang;Zhang, Lin;Yi, Lu;Jiang, Zhi-Qiang;Ke, Yang;Wang, Xiao-Shan;Xiong, Ying-Ying;Han, Wei-Qin;Zhou, Xiao;Liu, Chun;Yu, Xie
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권8호
    • /
    • pp.3267-3272
    • /
    • 2015
  • Purpose: To retrospective assess the potential predictors for relapse and create an effective clinical mode for surveillance after orchidectomy in clinical stage I non-seminomatous germ cell testicular tumors (CSI-NSGCTs). Materials and Methods: We analyzed data for CSI-NSGCTs patients with non-lymphatic vascular invasion, %ECa < 50% (percentage of embryonal carcinoma < 50%), and negative or declining tumor markers to their half-life following orchidectomy (defined as low-risk patients); these patients were recruited from four Chinese centers between January 1999 and October 2013. Patients were divided into active surveillance group and retroperitoneal lymph node dissection (RPLND) group according to different therapeutic methods after radical orchidectomy was performed. The disease-free survival rates (DFSR) and overall survival rates (OSR) of the two groups were compared by Kaplan-Meier analysis. Results: A total of 121 patients with CSI-NSGCT were collected from four centers, and 81 low-risk patients, including 54 with active surveillance and 27 with RPLND, were enrolled at last. The median follow-up duration was 66.2 (range 6-164) months in the RPLND group and 65.9 (range 8-179) months in the surveillance group. OSR was 100% in active surveillance and RPLND groups, and DFSR was 89.8% and 87.0%, respectively. No significant difference was observed between these two groups ($X_2=0.108$, P=0.743). No significant difference was observed between the patients with a low percentage of embryonal carcinoma (<50%) and those without embryonal carcinoma (87.0% and 91.9%, $X_2=0.154$, P=0.645). No treatment-related complications were observed in the active surveillance group whereas minor and major complications were observed in 13.0% and 26.1% of the RPLND group, respectively. Conclusions: Active surveillance resulted in similar DFSR and OSR compared with RPLND in our trial. Patients with low-risk CSI-NSGCTs could benefit from risk-adapted surveillance after these patients were subjected to radical orchidectomy.

종격동에 발생한 거대 미성숙기형종 -1례 보고- (Huge Immature Teratoma of Mediastinum - A case report -)

  • 강재걸
    • Journal of Chest Surgery
    • /
    • 제22권5호
    • /
    • pp.867-872
    • /
    • 1989
  • Primary mediastinal immature teratoma is a rare germinal tumor which includes various elements of mature teratoma, choriocarcinoma, yolk sac carcinoma, embryonal carcinoma, and seminoma in some proportions. The tumor is virtually restricted to young man and the response to surgery and radiotherapy are poor. Recently, we experienced a case of primary mediastinal immature teratoma with elevated serum [-HCG and [-fetoprotein in 18 years old man. The well-encapsulated mass, weighing 4.5 kg, was completely resected and then adjuvant combination chemotherapy was tried with Vincristine, Bleomycin, and Cisplatin. Radical excision of tumor and adjuvant chemotherapy would appear to produce better result than have been reported in other cases. The postoperative course was uneventful and the tumor markers were returned to normal range.

  • PDF

NgR1 Expressed in P19 Embryonal Carcinoma Cells Differentiated by Retinoic Acid Can Activate STAT3

  • Lee, Su In;Yun, Jieun;Baek, Ji-Young;Jeong, Yun-Ji;Kim, Jin-Ah;Kang, Jong Soon;Park, Sun Hong;Kim, Sang Kyum;Park, Song-Kyu
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제19권2호
    • /
    • pp.105-109
    • /
    • 2015
  • NgR1, a Nogo receptor, is involved in inhibition of neurite outgrowth and axonal regeneration and regulation of synaptic plasticity. P19 embryonal carcinoma cells were induced to differentiate into neuron-like cells using all trans-retinoic acid and the presence and/or function of cellular molecules, such as NgR1, NMDA receptors and STAT3, were examined. Neuronally differentiated P19 cells expressed the mRNA and protein of NgR1, which could stimulate the phosphorylation of STAT3 when activated by Nogo-P4 peptide, an active segment of Nogo-66. During the whole period of differentiation, mRNAs of all of the NMDA receptor subtypes tested (NR1, NR2A-2D) were consistently expressed, which meant that neuronally differentiated P19 cells maintained some characteristics of neurons, especially central nervous system neurons. Our results suggests that neuronally differentiated P19 cells expressing NgR1 may be an efficient and convenient in vitro model for studying the molecular mechanism of cellular events that involve NgR1 and its binding partners, and for screening compounds that activate or inhibit NgR1.